Rosetta Genomics Identifies 49 microRNAs with Potential to Provide Molecular Biomarkers and Drug Target Candidates
News May 20, 2010
Rosetta Genomics, Ltd. announces the publication of a study entitled, “Discovery of microRNAs and other small RNAs in solid tumors,” in the online edition of Nucleic Acid Research. The article was authored by Rosetta Genomics scientists including Dr. Eti Meiri and Einat Sitbon.
“So far this year, we have had six peer-reviewed articles published on our microRNA technology. These publications are a further demonstration of how Rosetta Genomics is maintaining a leadership position in the development of microRNAs for personalized medicine applications.”
“Our discovery of these new microRNAs gives us direct and exclusive access to 49 novel microRNAs, each one of which has the potential to be, alone or in combination with other microRNAs, a diagnostic biomarker, response biomarker or drug target. In addition, we have filed patent applications on each of these newly discovered microRNAs to enhance our expanding IP portfolio,” stated Kenneth A. Berlin, President and CEO of Rosetta Genomics.
“So far this year, we have had six peer-reviewed articles published on our microRNA technology. These publications are a further demonstration of how Rosetta Genomics is maintaining a leadership position in the development of microRNAs for personalized medicine applications.” The comprehensive database and proprietary technologies we have developed over the years are significant assets that allow us to lead in this area. They enable us to efficiently identify, extract, and quantify microRNAs, and transform them into commercially viable diagnostics, response biomarkers and therapeutics. This unrivaled set of capabilities allows us to harness the power of microRNAs as we work to improve healthcare worldwide,” added Mr. Berlin.
Novel Chemistry Technique Simplifies Late-Stage Modification of Drug CompoundsNews
Chemists at The Scripps Research Institute (TSRI) have invented a technique that overcomes a long-standing problem in organic chemistry and should streamline the process of discovery and development for many new drugs.READ MORE
Dipstick Technology Enables Rapid Diagnosis AnywhereNews
A new Australian study has reported a revolutionary dipstick technology that allows DNA and RNA to be extracted from living organisms in as little as 30 seconds.READ MORE
Revolutionary Imaging Technique Uses CRISPR to Map DNA MutationsNews
The new high-speed AFM method can map DNA to a resolution of tens of base pairs while creating images up to a million base pairs in size. And it does it using a fraction of the amount of specimen required for DNA sequencing.READ MORE
Comments | 0 ADD COMMENT
3rd Annual NGS Data Analysis and Informatics Conference
Feb 08 - Feb 09, 2018
3rd Annual Genome Editing & Engineering Conference
Feb 08 - Feb 09, 2018